Clinical Trials Directory

Trials / Completed

CompletedNCT03587623

Copeptin Serum Level in Liver Transplant Recipients

Status
Completed
Phase
Study type
Observational
Enrollment
38 (actual)
Sponsor
Medical University of Warsaw · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aim is to measure perioperative copeptin concentration in blood of liver transplant recipients and to assess whether there is a correlation between its level and hemodynamic derangement.

Conditions

Timeline

Start date
2018-07-04
Primary completion
2020-01-31
Completion
2020-01-31
First posted
2018-07-16
Last updated
2020-08-19

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03587623. Inclusion in this directory is not an endorsement.

Copeptin Serum Level in Liver Transplant Recipients (NCT03587623) · Clinical Trials Directory